Quantified tumor t1 is a generic early-response imaging biomarker for chemotherapy reflecting cell viability.
about
Multiparametric MRI analysis for the identification of high intensity focused ultrasound-treated tumor tissue.Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenationTranslational imaging endpoints to predict treatment response to novel targeted anticancer agents.Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells--a preclinical MR study in mice.Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PETFalse-negative MRI biomarkers of tumour response to targeted cancer therapeuticsIn vivo MRI follow-up of murine tumors treated by electrochemotherapy and other electroporation-based treatments.Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaTumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.Functional MRI and CT biomarkers in oncology.Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.Scanning electron microscopy with an ionic liquid reveals the loss of mitotic protrusions of cells during the epithelial-mesenchymal transition.Prostate T(1) quantification using a magnetization-prepared spiral technique.Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom.
P2860
Q27323217-8C509264-E993-48BA-ABCA-B74C70BC522CQ30377914-FF8A6A24-205D-47D5-827D-FBEDFC2A6347Q30465097-27522A09-0E0E-4BB0-9039-41A71836A2BDQ30757279-B2259F84-B3CD-4B77-AF54-858AD0FF8CCDQ30934034-C4250F7A-627F-401E-B34F-92E1504B1F3DQ33904265-AA1E0F5C-CB5E-40C2-882F-DD3132282071Q34041370-7CAF8556-8F5C-482C-B376-7DD9C512ECD5Q34273077-7029EE24-DBBF-48BF-BCC7-B1813EFE6F13Q34282717-FB94ED0C-5046-426B-9B6A-55B0DE77391BQ34983575-FC290378-D234-4EA3-8B33-DEDE46A6F8C8Q35670736-5BA0F6B3-B561-480B-8242-A9FB29DCF070Q37182194-BE7D7307-2380-4E3C-A56A-01672110A87DQ38314429-5E446A50-CD66-47F6-8959-09B5E0D7142BQ38634667-4B85448B-CECC-41BD-8FB1-CCCB7514AD18Q39574866-8172A1CC-2155-407E-8E35-F3623F49276EQ39788835-72A0A5FD-FE85-40C3-B3AD-92F5F2632A9EQ48759561-6178C34A-183C-48D1-8D20-ED112D4CAEB6
P2860
Quantified tumor t1 is a generic early-response imaging biomarker for chemotherapy reflecting cell viability.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@ast
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@en
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@nl
type
label
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@ast
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@en
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@nl
prefLabel
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@ast
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@en
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@nl
P2093
P1476
Quantified tumor t1 is a gener ...... apy reflecting cell viability.
@en
P2093
Catherine Cannet
Claudia Weidensteiner
Didier Laurent
Michael Stumm
Paul M J McSheehy
Peter R Allegrini
Stephan Ruetz
Stephane Ferretti
P304
P356
10.1158/1078-0432.CCR-09-0686
P407
P577
2009-12-15T00:00:00Z